Clinical Trial Update: A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab

View source ↗

Summary

This entry describes a real-world outcomes study evaluating long-term guselkumab use in inflammatory bowel diseases, focusing on ulcerative colitis and Crohn's …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen-Cilag A.G., Switzerland | Conditions: Inflammatory Bowel Disease, Colitis, Ulcerative | Status: NOT_YET_RECRUITING